United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025

Publisher Name :
Date: 24-Jun-2019
No. of pages: 95

The United States pneumococcal & meningococcal vaccines market is set to surpass US$ 7.5 Million by the year end of 2025.

“United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025” presents an in–depth assessment of the United States pneumococcal & meningococcal vaccines market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the most up–to–date industry data on the actual market situation and future outlook for United States pneumococcal & meningococcal vaccines market. The report includes historical data from 2015 to 2018 and forecasts until 2025.

The report contains a granular analysis of the present industry situations, market demands, reveal facts on the market size, revenues and provides forecasts through 2025. The report provides clear insight into current and future developments of the United States pneumococcal & meningococcal vaccines market. The report also explores detailed analysis of top 6 vaccines market assessment in United States from 2015 to 2018 and forecasts to 2025. The report also details the latest information about the pneumococcal & meningococcal vaccines pricing trends and analysis. It also covers reimbursement pattern and offers a clear view of the regulatory landscape.

Additionally, the report includes assessment of promising vaccines in the clinical development by major companies. Key trends in terms of collaboration, merger & acquisition, distribution, exclusive, licensing agreement and partnerships are analyzed with details. The report also explores detailed description of growth drivers and inhibitors of the United States pneumococcal & meningococcal vaccines market.

The report concludes with the profiles of major players in the United States pneumococcal & meningococcal vaccines market. The key market players are evaluated on various parameters such as business overview, vaccines portfolio and recent development.

The Major Companies Dominating this Market for its Products, Services and Continuous Product Developments are:

Pfizer, Merck, Sanofi Pasteur and GlaxoSmithKline (GSK)

Top 6 Vaccines Covered Under This Report Are:


  • Prevnar / Prevnar 13

  • Pneumovax 23

  • Menactra

  • Bexsero

  • Menveo

  • Trumenba


The Latest Industry Data Included in this Report:


  • United States Pneumococcal & Meningococcal Vaccines Market Size & Analysis (2015 – 2025)

  • United States Pneumococcal Vaccines Market Size & Analysis (2015 – 2025)

  • United States Meningococcal Vaccines Market Size & Analysis (2015 – 2025)

  • United States Pneumococcal & Meningococcal Vaccines Market Share & Y–o–Y Growth (%), 2017 – 2025

  • United States Pneumococcal Vaccines Market Share & Y–o–Y Growth (%), 2015 – 2025

  • United States Meningococcal Vaccines Market Share & Y–o–Y Growth (%), 2017 – 2025

  • United States Pneumococcal & Meningococcal Vaccines Market Assessment & Opportunity (Value),2015 – 2025

  • United States Pneumococcal & Meningococcal Vaccines Pricing Trends & Analysis

  • United States Pneumococcal & Meningococcal Vaccines Reimbursement Policies

  • United States Pneumococcal & Meningococcal Vaccines Regulatory System

  • Promising Pneumococcal & Meningococcal Vaccines in Clinical Development

  • Major Deals in the Vaccines Market

  • Key Drivers and Inhibitors of the United States Pneumococcal & Meningococcal Vaccines Market

  • Major Companies Analysis


The Report Answers the Following Questions about the United States Pneumococcal & Meningococcal Vaccines Market:


  • What is the size of the United States pneumococcal & meningococcal vaccines market during 2015 – 2025?

  • What will be the revenue generated by each vaccine during the forecast period?

  • Which vaccine provides highest market share?

  • How are the overall market and vaccines type growing?

  • What are the key drivers and inhibitors in the current market?

  • What are the various pneumococcal & meningococcal vaccines available in the United States?

  • How is the market predicted to develop in the future?

  • Who are the key players in this market space?

United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025

Table of Contents

1. Executive   Summary

2. United States Pneumococcal & Meningococcal Vaccines Market Size & Analysis (2015 – 2025)

3. United States Pneumococcal Vaccines Market Size & Analysis (2015 – 2025)

4. United States Meningococcal Vaccines Market Size & Analysis (2015 – 2025)

5. United States  Pneumococcal & Meningococcal Vaccines Market Share & Y–o–Y Growth (%), 2017 – 2025
5.1 United States  Pneumococcal Vaccines Market Share & Y–o–Y Growth (%), 2015 – 2025
5.2 United States  Meningococcal Vaccines Market Share & Y–o–Y Growth (%), 2017 – 2025

6. Key Drivers and Inhibitors of the United States Pneumococcal & Meningococcal Vaccines Market
6.1 Market Drivers
6.2 Market Inhibitors

7. United States Pneumococcal & Meningococcal Vaccines Market Assessment & Opportunity (Value),2015 – 2025
7.1 Prevnar / Prevnar 13
7.2 Pneumovax 23
7.3 Menactra
7.4 Bexsero
7.5 Menveo
7.6 Trumenba

8. United States Pneumococcal & Meningococcal Vaccines Pricing Trends & Analysis

9. United States Pneumococcal & Meningococcal Vaccines Reimbursement Policies & Regulatory System
9.1 Reimbursement Policies
9.2 Regulation System

10. Promising Pneumococcal & Meningococcal Vaccines in Clinical Development

11. Major Deals in the Vaccines Market
11.1 Merger & Acquisitions
11.2 Collaboration Deals
11.3 Licensing Agreement
11.4 Exclusive Agreement
11.5 Distribution Agreement
11.6 Partnerships

12. Key Companies Analysis
12.1 Sanofi Pasteur
12.1.1 Business Overview
12.1.2 Vaccines Portfolio
12.1.3 Recent Development
12.2 GlaxoSmithKline (GSK)
12.2.1 Business Overview
12.2.2 Vaccines Portfolio
12.2.3 Recent Development
12.3 Merck
12.3.1 Business Overview
12.3.2 Vaccines Portfolio
12.3.3 Recent Development
12.4 Pfizer
12.4.1 Business Overview
12.4.2 Vaccines Portfolio
12.4.3 Recent Development

List of Tables

Table 5–1: United States  Pneumococcal & Meningococcal Vaccines Market Share & Y–o–Y Growth (Percent), 2017 – 2018
Table 5–2: United States  Pneumococcal & Meningococcal Vaccines Market Share & Y–o–Y Growth Forecast (Percent), 2019 – 2025
Table 5–3: United States  Pneumococcal Vaccines Market Share & Y–o–Y Growth (Percent), 2015 – 2018
Table 5–4: United States  Pneumococcal Vaccines Market Share & Y–o–Y Growth Forecast (Percent), 2019 – 2025
Table 5–5: United States  Meningococcal Vaccines Market Share & Y–o–Y Growth (Percent), 2017 – 2018
Table 5–6: United States  Meningococcal Vaccines Market Share & Y–o–Y Growth Forecast (Percent), 2019 – 2025
Table 8–1: United States Pneumococcal & Meningococcal Adult Vaccines Price, 2019 – 2020
Table 8–2: United States Pneumococcal & Meningococcal Pediatric Vaccines Price, 2019 – 2020
Table 9–1: United States Simplified Regulatory Pathway from Preclinical to the Marketing Authorization
Table 11–1: Merger & Acquisitions in the Vaccines Market
Table 11–2: Collaboration Deal in the Vaccines Market
Table 11–3: Licensing Agreement in the Vaccines Market
Table 11–4: Exclusive Agreement in the Vaccines Market
Table 11–5: Distribution Agreement in the Vaccines Market
Table 6–6: Partnerships in the Vaccines Market

List of Figures

Figure 2–1: United States Pneumococcal & Meningococcal  Vaccines Market Size(Million US$),2015 – 2018
Figure 2–2: United States Pneumococcal & Meningococcal  Vaccines Market Size Forecast(Million US$),2019 – 2025
Figure 3–1: United States Pneumococcal Vaccines Market Size (Million US$),2015 – 2018
Figure 3–2: United States Pneumococcal Vaccines Market Size Forecast (Million US$),2019 – 2025
Figure 4–1: United States Meningococcal Vaccines Market Size (Million US$),2015 – 2018
Figure 4–2: United States Meningococcal Vaccines Market Size Forecast (Million US$),2019 – 2025
Figure 7–1: United States Prevnar/Prevnar 13 Market Value (Million US$),2015 – 2018
Figure 7–2: United States Prevnar/Prevnar 13 Market Value Forecast (Million US$),2019 – 2025
Figure 7–3: United States Pneumovax 23 Market Value (Million US$),2015 – 2018
Figure 7–4: United States Pneumovax 23 Market Value Forecast (Million US$),2019 – 2025
Figure 7–5: United States Menactra Market Value (Million US$),2015 – 2018
Figure 7–6: United States Menactra Market Value Forecast (Million US$),2019 – 2025
Figure 7–7: United States Bexsero Market Value (Million US$),2015 – 2018
Figure 7–8: United States Bexsero Market Value Forecast (Million US$),2019 – 2025
Figure 7–9: United States Menveo Market Value (Million US$),2015 – 2018
Figure 7–10: United States Menveo Market Value Forecast (Million US$),2019 – 2025
Figure 7–11: United States Trumenba Market Value (Million US$),2017 – 2018
Figure 7–12: United States Trumenba Market Value Forecast (Million US$),2019 – 2025

  • Global BCG Vaccine Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 96
    According to our LPI (LP Information) latest study, the global BCG Vaccine market size was valued at US$ 365.6 million in 2023. With growing demand in downstream market, the BCG Vaccine is forecast to a readjusted size of US$ 542.8 million by 2030 with a CAGR of 5.8% during review period. The research report highlights the growth potential of the global BCG Vaccine market. BCG Vaccine are expected to show stable growth in the future market. However, product differentiation, reducing cost......
  • Global Peptide Cancer Vaccine Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 115
    According to our LPI (LP Information) latest study, the global Peptide Cancer Vaccine market size was valued at US$ 535 million in 2023. With growing demand in downstream market, the Peptide Cancer Vaccine is forecast to a readjusted size of US$ 1978.2 million by 2030 with a CAGR of 20.5% during review period. The research report highlights the growth potential of the global Peptide Cancer Vaccine market. Peptide Cancer Vaccine are expected to show stable growth in the future market. How......
  • Global Cancer Vaccine Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
    Published: 26-Dec-2023        Price: US 3380 Onwards        Pages: 101
    Market Overview of Global Cancer Vaccine market: According to our latest research, the global Cancer Vaccine market looks promising in the next 5 years. As of 2022, the global Cancer Vaccine market was estimated at USD 7198.2 million, and it's anticipated to reach USD 33936.62 million in 2028, with a CAGR of 29.49% during the forecast years. A cancer vaccine is a type of immunotherapy that boost the body's natural defenses by stimulating the immune system to recognize and cur......
  • Global Lung Cancer Vaccines Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
    Published: 12-Dec-2023        Price: US 3380 Onwards        Pages: 102
    Market Overview of Global Lung Cancer Vaccines market: According to our latest research, the global Lung Cancer Vaccines market looks promising in the next 5 years. As of 2022, the global Lung Cancer Vaccines market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years. Lung Cancer Vaccines,A cancer vaccine for lung cance This report covers a research time span from 2018 to 2028, and ......
  • Global Cancer Vaccines Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
    Published: 07-Dec-2023        Price: US 3380 Onwards        Pages: 105
    Market Overview of Global Cancer Vaccines market: According to our latest research, the global Cancer Vaccines market looks promising in the next 5 years. As of 2022, the global Cancer Vaccines market was estimated at USD 5773.14 million, and it's anticipated to reach USD 15406.41 million in 2028, with a CAGR of 17.77% during the forecast years. This report covers a research time span from 2018 to 2028, and presents a deep and comprehensive analysis of the global Cancer Vacci......
  • Global Dendritic Cell Cancer Vaccine Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
    Published: 16-Nov-2023        Price: US 3380 Onwards        Pages: 110
    Market Overview of Global Dendritic Cell Cancer Vaccine market: According to our latest research, the global Dendritic Cell Cancer Vaccine market looks promising in the next 5 years. As of 2022, the global Dendritic Cell Cancer Vaccine market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years. Dendritic cells (DC) are one of the major antigen presenting cells found in lymphoid organs. The main fu......
  • Global BCG Vaccine Market Research Report 2023, Forecast to 2028
    Published: 14-Nov-2023        Price: US 2680 Onwards        Pages: 135
    BCG Vaccine is not given as part of the routine NHS vaccination schedule. It's given on the NHS only when a child or adult is thought to have an increased risk of coming into contact with TB. Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data for each segment and sub-segment. This way, clients can achieve all their goals while taking advantage o......
  • Global BCG Vaccine Professional Survey Report 2023, Forecast to 2028
    Published: 14-Nov-2023        Price: US 3280 Onwards        Pages: 105
    BCG Vaccine is not given as part of the routine NHS vaccination schedule. It's given on the NHS only when a child or adult is thought to have an increased risk of coming into contact with TB. Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data for each segment and sub-segment. This way, clients can achieve all their goals while taking advantage o......
  • Infectious Vaccine Collaboration and Licensing Deals 2016-2023
    Published: 01-Nov-2023        Price: US 3995 Onwards        Pages: 300
    Infectious Vaccine Collaboration and Licensing Deals provides a comprehensive understanding and unprecedented access to the infectious vaccine deals entered into by the worlds leading biopharma companies. Fully revised and updated, the report provides details of infectious vaccine deals from 2016 to 2023. The report provides a detailed understanding and analysis of how and why companies enter infectious vaccine deals. These deals tend to be multicomponent, starting with......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs